2021 Classic Lectures in Pathology: What You Need to Know: Breast Pathology
- Released
- 01/15/21
- Duration
- 6.75 Hours
- Price
- $540.00
Cart
CME Expiration Date 1/14/2024
|
|
Ductal Carcinoma In Situ of Breast: Updates and Differential Diagnoses
Charles D. Sturgis, M.D.
|
1.0 Hrs |
$90.00 |
Add to Cart |
|
|
Spindle Cell and Vascular Lesions of Breast
Christopher D.M. Fletcher, M.D., FRCPath
|
0.75 Hrs |
$67.50 |
Add to Cart |
|
|
Benign Breast Disease: Atypical Proliferative Lesion: Diagnosis and Breast Cancer Risk
David G. Hicks, M.D.
|
0.75 Hrs |
$67.50 |
Add to Cart |
|
|
Sclerosing Lesions of the Breast
David G. Hicks, M.D.
|
0.75 Hrs |
$67.50 |
Add to Cart |
|
|
Genomic in Breast Cancer Diagnosis and Treatment Planning: Is this an Opportunity to Enhance the Role of Pathologists in Multidisciplinary Care?
David G. Hicks, M.D.
|
1.25 Hrs |
$112.50 |
Add to Cart |
|
|
Breast Cancer Predictive Factor Testing (ER, PR & HER2): Bridging the Gap Between Diagnosis and Management
David G. Hicks, M.D.
|
1.0 Hrs |
$90.00 |
Add to Cart |
|
|
Ancillary Breast Cancer Studies: Rogue Cases, Challenges, Pitfalls and Trouble Shooting
David G. Hicks, M.D.
|
0.50 Hrs |
$45.00 |
Add to Cart |
|
|
Challenging Breast Pathology Case Studies
David G. Hicks, M.D.
|
0.75 Hrs |
$67.50 |
Add to Cart |
This CME Activity offers a practical review of breast pathology combining basic to advanced techniques, pearls and pitfalls to pathologic diagnosis and case reviews.
This CME activity is primarily intended and designed to educate pathologists.
Physicians: Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Educational Symposia designates this enduring material for a maximum of 6.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All activity participants are required to take a written or online test in order to be awarded credit. All course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.
AMA PRA Category 1 Credit(s)TM for these programs may be claimed until January 14, 2024.
This CME activity was planned and produced by Educational Symposia, the leader in continuing medical education since 1975.
This CME activity was planned and produced in accordance with the ACCME Essential Areas and Elements.
At the completion of this CME activity, subscribers should be able to:
-
Explain the spectrum of benign spindle cell lesions in the breast.
-
Describe sclerosing lesions of the breast.
-
Identify key features of genomic testing in breast cancer diagnosis and treatment planning.
-
Discuss breast cancer predictive factor testing (ER, PR & HER2).
-
Describe the diagnostic features and clinical significance of a variety of breast lesions with particular reference to the implications of these diagnoses in core needle biopsy specimens.
No special educational preparation is required for this CME activity
Professor, Department of Pathology and Laboratory Medicine
Director, Surgical Pathology Unit
University of Rochester Medical Center
Rochester, NY
Vice-Chair for Anatomic Pathology, Brigham & Women’s Hospital
Chief of Onco-Pathology, Dana-Farber Cancer Institute
Professor of Pathology, Harvard Medical School
Boston, MA
Staff Cytopathologist
R.J. Tomsich Pathology & Lab Medicine Institute
Cleveland Clinic
Associate Professor of Pathology
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland, OH
